Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells

Autor: Maria Fitria Setiawan, Ingo G.H. Schmidt-Wolf, Teresa Lozano, Francesca Garofano, Hans Weiher, Oliver Rudan, Roland Schmidt-Wolf, Bettina Langhans, Noelia Casares, Juan José Lasarte, Christian P. Strassburg, Annabelle Vogt, Maria A. Gonzalez-Carmona

Publikováno v: Anticancer Research. 39:5369-5374

Background/aim Cytokine-induced killer (CIK) cells are ex vivo expanded major histocompatibility complex (MHC)-unrestricted cytotoxic cells with promising effects against a variety of cancer types. Regulatory T-cells (T-reg) have been shown to reduce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17dad477aac81c1c16258d0bd3f294e
https://doi.org/10.21873/anticanres.13730

PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines.

Autor: Li Y; Department of Integrated Oncology (CIO), University Hospital Bonn, D-53127 Bonn, Germany., Sharma A; Department of Integrated Oncology (CIO), University Hospital Bonn, D-53127 Bonn, Germany.; Department of Neurosurgery, University Hospital Bonn, D-53127 Bonn, Germany., Bloemendal MWJR; Department of Biosciences, Hogeschool van Arnhem en Nijmegen University of Applied Sciences, 6525EM Nijmegen, The Netherlands., Schmidt-Wolf R; Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, D-53127 Bonn, Germany., Kornek M; Department of Medicine I, University Hospital Bonn, D-53127 Bonn, Germany., Schmidt-Wolf IGH; Department of Integrated Oncology (CIO), University Hospital Bonn, D-53127 Bonn, Germany.

Publikováno v: Oncology letters [Oncol Lett] 2021 Aug; Vol. 22 (2), pp. 613. Date of Electronic Publication: 2021 Jun 23.